We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SNSE market cap is 10.29M. The company's latest EPS is USD -23.9265 and P/E is -0.34.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.73M | -7.79M | -7.82M | -8.27M | -7.27M |
| Net Income | -7.99M | -7.14M | -7.25M | -7.77M | -6.86M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.45M | -37.48M | -50.19M | -37.06M | -32.61M |
| Net Income | -20.2M | -36.79M | -48.59M | -34.1M | -30.16M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 66.7M | 59.8M | 53.25M | 45.36M | 38.27M |
| Total Liabilities | 8.22M | 7.61M | 7.48M | 6.98M | 6.29M |
| Total Equity | 58.47M | 52.19M | 45.78M | 38.39M | 31.99M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.43M | 153.23M | 118.38M | 74.37M | 45.36M |
| Total Liabilities | 5.54M | 6.71M | 14.97M | 9.48M | 6.98M |
| Total Equity | -56.44M | 146.51M | 103.41M | 64.9M | 38.39M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.62M | -13.41M | -18.88M | -24.67M | -7.09M |
| Investing | 5.77M | 12.68M | 25.59M | 22.44M | 7.19M |
| Financing | -209k | -389k | -593k | -787k | -214k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.71M | -30.26M | -39.03M | -32.02M | -24.67M |
| Investing | -1.4M | -143.12M | 49.95M | 38.41M | 22.44M |
| Financing | 35.45M | 163.94M | -287k | -11.17M | -787k |
| Market Cap | 10.29M |
| Price to Earnings Ratio | -0.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.03 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 1.26M |
| Average Volume (1 week) | 3.65k |
| Average Volume (1 Month) | 63.41k |
| 52 Week Change | -37.95% |
| 52 Week High | 17.40 |
| 52 Week Low | 5.00 |
| Spread (Intraday) | 2.75 (28.95%) |
| Company Name | Sensei Biotherapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.senseibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
